Healthcare payers: a gate or translational bridge to personalized medicine?

Personalized Medicine
William J CanestaroRick Schatzberg

Abstract

Healthcare payers represent stakeholders who can act as either a bridge or a gate to the translation of personalized medicine into routine clinical practice. To date, the slow realization of the promise of personalized medicine has been partly attributable to the lack of clear evidence supporting the clinical utility of genetic and genomic tests and the lag in development of clinical guidelines for the use and interpretation of tests. These factors, along with a paucity of clear guidance from healthcare payers and clinical experience with genomic tests, serve as impediments to timely and consistent reimbursement decisions. The design of alternative strategies for collaborative evidence-generation, clinical decision support and educational initiatives for healthcare providers, patients and the payers themselves are critical needs to achieve the full benefit of personalized medicine in day-to-day healthcare settings.

References

Aug 1, 1967·Journal of Chronic Diseases·D Schwartz, J Lellouch
Apr 29, 1998·JAMA : the Journal of the American Medical Association·J LazarouP N Corey
Dec 21, 2000·Journal of Clinical Pharmacy and Therapeutics·D N KiortsisG Turpin
Apr 28, 2001·Trends in Molecular Medicine·B B SpearJ Huff
Jan 14, 2003·Archives of Internal Medicine·Marina A W Umans-EckenhausenJohn J P Kastelein
Feb 7, 2003·The New England Journal of Medicine·William E Evans, Howard L McLeod
Sep 25, 2003·JAMA : the Journal of the American Medical Association·Sean R TunisCarolyn M Clancy
Mar 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Shuen-Iu HungYuan-Tsong Chen
Jun 22, 2005·Annals of Internal Medicine·Athina TatsioniJoseph Lau
Aug 5, 2005·The New England Journal of Medicine·Lars Osterberg, Terrence Blaschke
Mar 16, 2006·Pharmacogenetics and Genomics·Shuen-Iu HungYuan-Tsong Chen
Aug 11, 2006·Nature Biotechnology·Keith Batchelder, Peter Miller
Oct 19, 2006·JAMA : the Journal of the American Medical Association·Daniel S BudnitzJoseph L Annest
Aug 2, 2007·Genetics in Medicine : Official Journal of the American College of Medical Genetics·James M GudgeonMarc S Williams
Aug 10, 2007·Clinical Pharmacology and Therapeutics·P A DeverkaR J Carlson
Nov 9, 2007·Circulation·Jeffrey L AndersonUNKNOWN Couma-Gen Investigators
Jan 10, 2008·Clinical Pharmacology and Therapeutics·M-S WenY-T Chen
Feb 8, 2008·The New England Journal of Medicine·Simon MallalUNKNOWN PREDICT-1 Study Team
Feb 19, 2008·Genetics in Medicine : Official Journal of the American College of Medical Genetics·David A FlockhartUNKNOWN ACMG Working Group on Pharmacogenetic Testing of CYP2C9, VKORC1 Alleles for Warfarin Use
Jun 12, 2008·Journal of the National Cancer Institute·Karyn Hede
Jul 3, 2008·The Annals of Pharmacotherapy·Chuenjid KongkaewDarren M Ashcroft
Jul 25, 2008·The New England Journal of Medicine·UNKNOWN SEARCH Collaborative GroupR Collins
Sep 12, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Spencer B CherryMichael B Nichol
Sep 25, 2008·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Steven M TeutschUNKNOWN EGAPP Working Group
Feb 11, 2009·Public Health Genomics·P A Deverka
Mar 11, 2009·Clinical Medicine : Journal of the Royal College of Physicians of London·Ronald L Zimmern
Apr 18, 2009·Genetic Testing and Molecular Biomarkers·Kristi D Zonno, Sharon F Terry
Jun 27, 2009·Public Health Genomics·G JavittK Hudson
Oct 10, 2009·Health Policy·Lisa M Meckley, Peter J Neumann
Oct 17, 2009·Journal of the American College of Cardiology·Deepak VooraGeoffrey S Ginsburg
Nov 7, 2009·Pharmacogenomics·Maha KadafourJaekyu Shin
Jan 1, 2010·Atherosclerosis·Abhijit GhatakPaul D Thompson
Feb 6, 2010·Health Affairs·Christopher J TrufferM Kent Clemens
Feb 20, 2010·Nature Reviews. Drug Discovery·Steven M PaulAaron L Schacht
Mar 20, 2010·Pharmacogenomics·Laurent Becquemont
Apr 13, 2010·Journal of the American College of Cardiology·Robert S EpsteinJ Russell Teagarden
Jul 20, 2010·Nature Genetics·Jonathan B SingerCharles A Paulding

❮ Previous
Next ❯

Citations

Jan 7, 2015·Journal of Personalized Medicine·Julius Alexander Steffen
Jan 1, 2013·Journal of Personalized Medicine·Julius Alexander Steffen, Jan Simon Steffen

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping
PCR

Software Mentioned

DNADirect
Medco

Related Concepts

Related Feeds

Adenocarcinoma, Clear Cell

Clear Cell Adenocarcinoma is a tumor that arises in the female genital tract and is characterized by cells that appear clear under the microscope. Discover the latest research here.

Related Papers

Genetics in Medicine : Official Journal of the American College of Medical Genetics
Patricia A DeverkaScott D Ramsey
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Nascimento do, E Asano
Arthroscopy : the Journal of Arthroscopic & Related Surgery : Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association
L L Johnson
© 2022 Meta ULC. All rights reserved